Australia markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6100+0.0100 (+0.62%)
At close: 04:00PM EDT
1.6000 -0.01 (-0.62%)
After hours: 07:30PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-50,389
-50,389
-45,338
-33,768
-16,224
Depreciation & amortisation
2,741
2,741
1,695
1,304
1,266
Stock-based compensation
2,600
2,600
2,154
1,614
1,465
Change in working capital
15,012
15,012
-833
-2,588
-2,261
Other working capital
-37,436
-37,436
-43,527
-33,267
-15,503
Other non-cash items
-
-
-
366
346
Net cash provided by operating activities
-33,221
-33,221
-41,886
-33,075
-15,301
Cash flows from investing activities
Investments in property, plant and equipment
-4,215
-4,215
-1,641
-192
-202
Purchases of investments
-106,977
-106,977
-42,118
-126,506
-21,066
Sales/maturities of investments
91,050
91,050
90,825
35,082
28,150
Net cash used for investing activities
-20,127
-20,127
47,245
-91,566
6,900
Cash flows from financing activities
Debt repayment
-394
-394
-66
0
-9,083
Common stock issued
66,519
66,519
5,472
109,952
25,216
Net cash used provided by (used for) financing activities
66,230
66,230
5,451
110,025
16,143
Net change in cash
12,882
12,882
10,810
-14,616
7,742
Cash at beginning of period
13,146
13,146
2,336
16,952
9,210
Cash at end of period
26,028
26,028
13,146
2,336
16,952
Free cash flow
Operating cash flow
-33,221
-33,221
-41,886
-33,075
-15,301
Capital expenditure
-4,215
-4,215
-1,641
-192
-202
Free cash flow
-37,436
-37,436
-43,527
-33,267
-15,503